Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.002 Å; R factor = 0.028; wR factor = 0.075; data-to-parameter ratio = 9.4.
In the title compound [systematic name: 2-hydroxy-N-(5-nitro-1,3-thiazol-2-yl)benzamide pyridine monosolvate], C 10 H 7 N 3 O 4 SÁC 5 H 5 N, the dihedral angle between the pyridine and benzamide rings is 80.55 (7) . An intamolecular O-HÁ Á ÁN hydrogen bond occurs in the tizoxanide. In the crystal, the components are linked by an O-HÁ Á ÁN hydrogen bond, forming a zigzag chain along the c axis. Aromaticinteractions between inversion-related pyridine rings [centroid-centroid distance = 3.803 (6) Å ] are also observed.
Related literature
For the biological activity of tizoxanide, see: Rao et al. (2009); Gargala et al. (2000) ; Dubreuil et al. (1996) ; Ashton et al. (2010) ; Korba, Elazar et al. (2008) ; Zhao et al. (2010) . For related structures and background to the bioactivity of tizoxanide, see: Pankuch & Appelbaum (2006) ; Stettler et al. (2003) ; Broekhuysen et al. (2000) . For details on experimental methods used to obtain this form and analogues, see: Navarrete- Vazquez et al. (2011) . For a pyridine-solvated forms, see: Dong et al. (2011) . For additional literature on related tizoxanide thiazolide compounds, see: Megraud et al. (1998) Table 1 Hydrogen-bond geometry (Å , ). (Stachulski et al., 2011a) . In humans, once orally administered, nitazoxanide is hydrolyzed in plasma to its active metabolite tizoxanide (TIZ), which is 99% protein bound (Broekhuysen et al., 2000; Ashton et al., 2010) . Nitazoxanide exhibits a broad spectrum of activities against intracellular and extracellular protozoa, helminthes, aerobic and anaerobic bacteria, and viruses infecting humans and animals (Hemphill et al., 2006; Rossignol et al., 2006; Korba, Montero et al., 2008; Zhao et al., 2010; Stachulski et al., 2011b) .
In the present study, tizoxanide was prepared via deacetylation of nitazoxanide in pyridine and it crystallized as a 1:1 ratio complex with pyridine as crystals. Thermogravimetric analysis was performed to study the thermal stability of the title complex, which indicated a one-step molecular weight loss of 22.43% corresponding to one pyridine molecule in the temperature range of 333-373 K, confirming a 1:1 ratio complex of tizoxanide-pyridine (theoretical weight loss 22.97%).
The tizoxanide and pyridine are linked through hydrogen bond O1-H···N8 (bond distance = 2.567 Å). A stable crystal was formed through intramolecular O1-H···N7 (bond distance = 2.625 Å) and intermolecular O1-H···N8 hydrogenbonding interactions involving the benzamide group and the pyridine molecule. It is arresting that π-π interactions play an important role in the molecular packing. Inversion-related pyridine molecules are linked by π-π interactions [centroidcentroid distance = 3.803 (6) Å], which stabilize the crystal. By comparison with X-ray of prodrug nitazoxanide (Bruno et al., 2010) , tizoxanide has stronger intramolecular hydrogen bonds. These hydrogen bonds may be useful for pharmaceutical preparation of tizoxanide. The molecular and crystal structures are stabilized by intra-(O1-H···N7) and intermolecular (O1-H···N8, π-stacking) interactions respectively, which give a great stability to the crystal building.
When the drug crystallized from different solvents, the crystal form may be changed and then altering a drug's properties, such as melting point and solubility (Trask et al., 2004) . We speculated that the replacement of a weak alkaline solvent or solid compound containing the pyridine ring may form the corresponding crystals made of different formulations of active drugs for tizoxanide. Obviously, crystal form of the title compound is different from prodrug nitazoxanide, which suggests that changing solvent or pyridine derivatives may form new crystals and new dosage forms of drugs. This is our future work.
Experimental
A solution of 80 mg of nitazoxanide in 250 ul of pyridine was stirred for 15 min at 333 K and left to crystallize at 293 K overnight. A size suitable flaxen needle was attained for X-ray analysis.
Thermogravimetric analysis for the title complex was performed using a NETZSCH STA409 instrument with sample.
The sample was placed in an aluminium cell, heated at 5 °C min -1 and purged with nitrogen gas flowing at 20 cm 3 min 
Figure 1
A view of the molecular structure of the title compound (I). The displacement ellipsoids are at the 50% probability level.
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Figure 2
The two-dimensional plane formed by the hydrogen bonds of the molecules; dashed lines represent hydrogen bonds and some of the H atoms have been omitted for reasons of clarity.
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Figure 3
The thermogravimetric analysis of the title compound showing a one-step molecular weight loss of 22.43%
corresponding to one pyridine molecule.
2-Hydroxy-N-(5-nitro-1,3-thiazol-2-yl)benzamide pyridine monosolvate
Crystal data 0.0200 (7) 0.0237 (7) 0.0195 (7) 0.0088 (6) 0.0045 (6) 0.0049 (6) C10 0.0200 (7) 0.0232 (7) 0.0176 (7) 0.0096 (6) 
